Patents by Inventor Sivi Ouwerkerk-Mahadevan

Sivi Ouwerkerk-Mahadevan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating multiple sclerosis
    Patent number: 11951097
    Abstract: The disclosure relates to methods of treating multiple sclerosis. Also provided are pharmaceutical products containing ponesimod, instructions for use of ponesimod, methods for selling a drug product containing ponesimod, and methods for reducing clinical management events before or during treatment of multiple sclerosis.
    Type: Grant
    Filed: October 10, 2022
    Date of Patent: April 9, 2024
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Allitia DiBernardo, Tatiana Sidorenko, Michel Burcklen, Sivi Ouwerkerk-Mahadevan, Andrea Vaclavkova, Brian Patrick Hennessy, Hilke Kracker
  • Methods Of Treating Multiple Sclerosis
    Publication number: 20230143217
    Abstract: The disclosure relates to methods of treating multiple sclerosis. Also provided are pharmaceutical products containing ponesimod, instructions for use of ponesimod, methods for selling a drug product containing ponesimod, and methods for reducing clinical management events before or during treatment of multiple sclerosis.
    Type: Application
    Filed: October 10, 2022
    Publication date: May 11, 2023
    Inventors: Allitia DiBernardo, Tatiana Sidorenko, Michel Burcklen, Sivi Ouwerkerk-Mahadevan, Andrea Vaclavkova, Brian Patrick Hennessy, Hilke Kracker
  • Aryl and heteroaryl morpholine derivatives
    Patent number: 7354920
    Abstract: Compounds of formula (I) wherein Rx is H; Ry is H or C1-C4 alkyl; each Rz is independently H or C1-C4 alkyl; X represents O; Y represents OH or OR; R is C1-C4 alkyl; and Ar1 and Ar2 are optionally substituted phenyl or 5- or 6-membered heteroaryl rings are selective inhibitors of the reuptake of norepinephrine.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: April 8, 2008
    Assignee: Eli Lilly and Company
    Inventors: Manuel Javier Cases-Thomas, Helen Louise Haughton, Robin George Simmonds, Hélène Catherine Eugénie Rudyk, Magnus Wilhelm Walter, Sivi Ouwerkerk-Mahadevan, John Joseph Masters, Carlos Lamas-Peteira
  • Aryl and heteroaryl morpholine derivatives
    Publication number: 20060003998
    Abstract: Compounds of formula (I) wherein Rx is H; Ry is H or C1-C4 alkyl; each Rz is independently H or C1-C4 alkyl; X represents O; Y represents OH or OR; R is C1-C4 alkyl; and Ar1 and Ar2 are optionally substituted phenyl or 5- or 6-membered heteroaryl rings are selective inhibitors of the reuptake of norepinephrine.
    Type: Application
    Filed: August 18, 2003
    Publication date: January 5, 2006
    Applicant: ELI LILLY AND COMPANY
    Inventors: Manuel Cases-Thomas, Helen Haughton, Robin Simmonds, Helene Rudyk, Magnus Walter, Sivi Ouwerkerk-Mahadevan